Cancer Screening

Next-generation Cologuard exhibited improved colorectal cancer specificity and sensitivity compared with results of the FDA registrational trial that led to approval of the noninvasive screening test, its manufacturer reported.

CHICAGO — A study that assessed the feasibility of lung cancer screening for certain nonsmokers yielded a higher invasive adenocarcinoma detection rate than the National Lung Screening Trial, which assessed screening for smokers who met key risk criteria.

Compared with reoffering colonoscopy and fecal immunochemical test alone, offering a blood test as a secondary option resulted in a nearly twofold increase in colorectal cancer screening in veterans who had declined first-line screening.

CHICAGO — A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current noninvasive screening options.

CHICAGO — Colorectal cancer screening rates at federally qualified health centers were significantly higher in states that expanded Medicaid under the Affordable Care Act vs. states that did not, according to data at Digestive Disease Week.

When we reflect on the overall impact of colorectal cancer screening over the past two decades, we see the result of a collaboration of physicians and organizations who joined forces to work toward one of our great public health successes.

Despite a decline in the overall incidence of colorectal cancer in the U.S., recent population-based data from the American Cancer Society show an alarming shift to younger age and more advanced disease at diagnosis.

WASHINGTON — A lung nodule detection program saw an increase in low-dose CT for Black and Hispanic individuals after addressing screening barriers, according to research presented at the American Thoracic Society International Conference.

A commonly asked questions sheet addressing needs related to comprehension of lung cancer screening results was positively received by patients and clinicians, according to study results published in CHEST.

Cervical cancer screening rates are low across the board, but disparities for Black patients persist, according to researchers.